379 related articles for article (PubMed ID: 15211941)
1. Medicines pricing singled out.
Buchanan E
S Afr Med J; 2004 May; 94(5):334. PubMed ID: 15211941
[No Abstract] [Full Text] [Related]
2. Pharmaceuticals and medical devices: business practices.
Steiner DJ
Issue Brief Health Policy Track Serv; 2013 Dec; ():1-36. PubMed ID: 24482889
[No Abstract] [Full Text] [Related]
3. Should the patent system for new medicines be abolished?
DiMasi JA; Grabowski HG
Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100
[No Abstract] [Full Text] [Related]
4. Pharmaceuticals and medical devices: business practices. Issue brief.
Steiner DJ
Issue Brief Health Policy Track Serv; 2012 Dec; ():1-36. PubMed ID: 23297448
[No Abstract] [Full Text] [Related]
5. South Africa's moral victory.
Lancet; 2001 Apr; 357(9265):1303. PubMed ID: 11343727
[No Abstract] [Full Text] [Related]
6. Pharmaceuticals: drug importation--2005. End of Year Issue Brief.
Varma P; Seay M
Issue Brief Health Policy Track Serv; 2005 Dec; ():1-20. PubMed ID: 16708457
[No Abstract] [Full Text] [Related]
7. Fake pharmaceuticals: how they and relevant legislation or lack thereof contribute to consistently high and increasing drug prices.
Moken MC
Am J Law Med; 2003; 29(4):525-42. PubMed ID: 15119247
[No Abstract] [Full Text] [Related]
8. Pharmaceuticals and medical devices: business practices.
; Steiner DJ
Issue Brief Health Policy Track Serv; 2012 Jan; ():1-35. PubMed ID: 22423396
[No Abstract] [Full Text] [Related]
9. Pandora's Prescription: The Pharmaceutical Pricing
Pederson T
FASEB J; 2017 Nov; 31(11):4661-4662. PubMed ID: 29093000
[No Abstract] [Full Text] [Related]
10. Pharmaceuticals and medical devices: cost savings.
Steiner DJ
Issue Brief Health Policy Track Serv; 2013 Dec; ():1-32. PubMed ID: 24482891
[No Abstract] [Full Text] [Related]
11. Pharmaceuticals and medical devices: cost savings.
; Steiner DJ
Issue Brief Health Policy Track Serv; 2012 Jan; ():1-37. PubMed ID: 22403843
[No Abstract] [Full Text] [Related]
12. Early benefit assessment for pharmaceuticals in Germany: lessons for policymakers.
Schlette S; Hess R
Issue Brief (Commonw Fund); 2013 Oct; 29():1-9. PubMed ID: 24171232
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceuticals and medical devices: cost savings. End-of-year issue brief.
Health Policy Tracking Service, A Service of Thomson Reuters/West
Issue Brief Health Policy Track Serv; 2011 Jan; ():1-21. PubMed ID: 21374837
[No Abstract] [Full Text] [Related]
14. Differential pricing of new pharmaceuticals in lower income European countries.
Kaló Z; Annemans L; Garrison LP
Expert Rev Pharmacoecon Outcomes Res; 2013 Dec; 13(6):735-41. PubMed ID: 24219049
[TBL] [Abstract][Full Text] [Related]
15. The Myth of the Free Market for Pharmaceuticals.
Conti RM; Frank RG; Cutler DM
N Engl J Med; 2024 Apr; 390(16):1448-1450. PubMed ID: 38647106
[No Abstract] [Full Text] [Related]
16. [Development costs, regulation and audit in the German SHI Drug Sector].
Kamp F; Walter P; Bücheler R
Gesundheitswesen; 2014 Jan; 76(1):7-18. PubMed ID: 24446140
[No Abstract] [Full Text] [Related]
17. Pharmaceuticals and medical devices: Medicare Part D. Issue brief.
Steiner DJ
Issue Brief Health Policy Track Serv; 2012 Dec; ():1-32. PubMed ID: 23297447
[No Abstract] [Full Text] [Related]
18. US drug shortages are set to reach record high in 2011, report says.
Tanne JH
BMJ; 2011 Dec; 343():d8307. PubMed ID: 22194406
[No Abstract] [Full Text] [Related]
19. Market watch: pricing strategies for emerging markets.
Lineberry N; Snyder E; Gunda S
Nat Rev Drug Discov; 2011 Aug; 10(8):567. PubMed ID: 21804586
[No Abstract] [Full Text] [Related]
20. Assessment of the opportunities for pharmaceutical manufacturers in emerging markets.
Anderson T; Olson J; Sobelman D
J Manag Care Pharm; 2009 Jun; 15(5):396-402. PubMed ID: 19496636
[No Abstract] [Full Text] [Related]
[Next] [New Search]
